Sotatercept reduces pulmonary vascular resistance in pulmonary arterial hypertension
A gender gap in negotiation emerges between boys and girls as early as age eight
1 April 2021Poorer and minority older adults are suspicious of the US health care system
1 April 2021Sotatercept reduces pulmonary vascular resistance in pulmonary arterial hypertension
For patients receiving background therapy for pulmonary arterial hypertension, treatment with sotatercept results in a reduction in pulmonary vascular resistance, according to a study published in the April 1 issue of the New England Journal of Medicine.
